Nearly 20 percent of American adolescents, or one in five, has suffered a concussion, according to newly released statistics.
Researchers have discovered a protein that could help diagnose a degenerative brain disease commonly found in athletes, veterans of military service and others who have experienced brain trauma.
Digital devices designed to monitor the wearer’s health in much greater detail than current models will need regulatory approval, and Apple Inc., Fitbit Inc. and seven other companies will take part in a program to speed the approval process, the U.S. health regulator said.
PTC Therapeutics Inc. failed to supply persuasive evidence that its experimental drug to treat a form of Duchenne muscular dystrophy is effective, the U.S. Food and Drug Administration said, dealing a blow to the company’s years-long effort to bring the drug to market.
Europe’s drugs regulator could lose more than 70 percent of staff, making it unable to function, if politicians pick the wrong new home for the London-based agency, it warned on Tuesday.
Drug developer Axovant Sciences Ltd. said it would stop testing the company’s lead drug in Alzheimer’s after it failed to meet the main goals of a late-stage trial.
New Novartis Chief Executive Officer Vasant Narasimhan has a goal of saving 25 percent of clinical trial costs by using digital technology.
Genocea Biosciences is pivoting a development strategy to focus on development of neoantigen cancer treatments and scrapping its Phase III-ready herpes drug.
By Susan Cornwell, Yasmeen Abutaleb WASHINGTON (Reuters) – U.S. Senator Susan Collins rebuffed intense lobbying from fellow Republicans and the promise of money for her state in deciding on Monday to oppose – and likely doom – her party’s last-ditch effort to repeal Obamacare. The most moderate of Republican senators joined John McCain […]
Authorities from a record 123 countries, including the U.S. FDA, have taken action against hundreds of businesses suspected of illegally selling medicines over the internet, officials said.